Model-Informed Drug Development for Geriatric Populations
Journal: Geriatric Pharmacology
Model-Informed Drug Development (MIDD) is a methodologic paradigm that leverages mathematical or computational modelling and simulation. It combines non-clinical and clinical data and other existing knowledge to generate evidence that facilitates decision-making during drug development. It is transforming approaches to evidence synthesis and integration, as well as provision of actionable insights for contemporary d…